US Patent Issued to Verseau Therapeutics on Sept. 22 for "Anti-VSIG4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,011, issued on Sept. 22, was assigned to Verseau Therapeutics Inc. (Bedford, Mass.).

"Anti-VSIG4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof" was invented by Tatiana I. Novobrantseva (Wellesley, Mass.), Igor Feldman (Waltham, Mass.), Stephen L. Sazinsky (Winchester, Mass.), Elizabeth Culyba (Arlington, Mass.), Phuong Anh Nguyen (Melrose, Mass.) and Maja Razlog (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is based, in part, on the discovery of anti-VSIG4 composition (e.g., monoclonal antibodies and antigen-binding fragments thereof), that regulate myeloid ce...